ACE Ventures leads Prevision Medicine USD 5.4 million seed round
Prevision Medicine raised a $5.4 million Seed round led by ACE Ventures to commercialize a functional precision medicine cancer test. The startup targets hematological malignancies and solid tumors, using a single-cell platform to test living tumor cells against drug libraries. Capital earmarked for regulatory clearanc